Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$696M |
| 2 |
Moderna
MRNA
|
+$487M |
| 3 |
Analog Devices
ADI
|
+$272M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$261M |
| 5 |
Tesla
TSLA
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$670M |
| 2 |
Microsoft
MSFT
|
+$376M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$335M |
| 4 |
Alibaba
BABA
|
+$323M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.32% |
| 2 | Healthcare | 13.34% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.65% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGS
3526
DELISTED
PlayAGS
AGS
| $740K | ﹤0.01% |
94,004
+6,366
| +7% | +$50.6K |
|
3527
Foghorn Therapeutics
FHTX
$394M
| $740K | ﹤0.01% |
53,118
+1,699
| +3% | +$18.8K |
|
3528
TherapeuticsMD
TXMD
$24.1M
| $739K | ﹤0.01% |
19,932
+489
| +3% | +$21.7K |
|
|
PSTX
3529
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $739K | ﹤0.01% |
101,388
+18,488
| +22% | +$159K |
|
|
EBET
3530
DELISTED
EBET, INC. Common Stock
EBET
| $739K | ﹤0.01% |
+734
| New | +$593K |
|
3531
Adicet Bio
ACET
$77.3M
| $737K | ﹤0.01% |
5,887
+450
| +8% | +$55.8K |
|
|
BELFB
3532
Bel Fuse Inc Class B
BELFB
$4.25B
| $731K | ﹤0.01% |
58,902
-59,505
| -50% | -$798K |
|
3533
iShares US Utilities ETF
IDU
$1.38B
| $731K | ﹤0.01% |
9,272
| – | – |
|
3534
Century Therapeutics
IPSC
$355M
| $727K | ﹤0.01% |
+28,932
| New | +$783K |
|
|
AWH
3535
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $727K | ﹤0.01% |
14,912
+117
| +0.8% | +$7.23K |
|
3536
Enovix
ENVX
$966M
| $726K | ﹤0.01% |
+43,928
| New | +$661K |
|
3537
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.32B
| $725K | ﹤0.01% |
12,079
+1,929
| +19% | +$119K |
|
3538
Immersion
IMMR
$247M
| $725K | ﹤0.01% |
105,927
+30,350
| +40% | +$226K |
|
3539
Citius Pharmaceuticals
CTXR
$21M
| $724K | ﹤0.01% |
14,277
+985
| +7% | +$49.4K |
|
|
AHT
3540
Ashford Hospitality Trust
AHT
$19.8M
| $718K | ﹤0.01% |
4,875
+974
| +25% | +$165K |
|
|
MLNK
3541
DELISTED
MeridianLink
MLNK
| $718K | ﹤0.01% |
+32,112
| New | +$792K |
|
3542
Travelzoo
TZOO
$75.5M
| $717K | ﹤0.01% |
61,876
+19,530
| +46% | +$248K |
|
3543
Clover Health Investments
CLOV
$2.41B
| $716K | ﹤0.01% |
96,888
+43,712
| +82% | +$374K |
|
3544
Ouster
OUST
$3.25B
| $714K | ﹤0.01% |
9,753
+1,506
| +18% | +$139K |
|
3545
Hims & Hers Health
HIMS
$6.71B
| $713K | ﹤0.01% |
94,569
+51,495
| +120% | +$436K |
|
3546
Tenaya Therapeutics
TNYA
$164M
| $712K | ﹤0.01% |
+34,481
| New | +$741K |
|
|
URG
3547
Ur-Energy
URG
$533M
| $712K | ﹤0.01% |
414,023
+46,623
| +13% | +$62.5K |
|
|
PTRA
3548
DELISTED
Proterra Inc. Common Stock
PTRA
| $712K | ﹤0.01% |
+70,436
| New | +$796K |
|
|
TIGR
3549
UP Fintech Holding
TIGR
$833M
| $710K | ﹤0.01% |
67,013
-69
| -0.1% | -$1.08K |
|
3550
Educational Development Corp
EDUC
$11.8M
| $709K | ﹤0.01% |
73,422
-11,117
| -13% | -$118K |
|
Similar funds
Bank of New York Mellon's Q3 2021 Portfolio in Review
As of Q3 2021, Bank of New York Mellon held 4,634 positions worth $512B, down 0.89% from $517B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Bank of New York Mellon's Q3 2021 filing shows 243 new, 2,575 increased, 1,388 reduced and 114 closed positions. Its largest new stake was GXO Logistics: 863,863 shares worth $67.8M. The largest sale was Apple, an estimated $670M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q3 2021 buy was GXO Logistics: 863,863 shares worth $67.8M.
- Bank of New York Mellon added most to Vanguard S&P 500 ETF in Q3 2021, an estimated $696M increase.
- Bank of New York Mellon's biggest Q3 2021 reduction was Apple, cutting an estimated $670M.
- Bank of New York Mellon fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $335M.
- Bank of New York Mellon's ten largest holdings make up 20% of its $512B portfolio in Q3 2021.
- Bank of New York Mellon opened 243 new positions and closed 114 in Q3 2021.
- Bank of New York Mellon's portfolio value fell 0.89% quarter-over-quarter to $512B.
Based on Bank of New York Mellon's 13F filing for Q3 2021, filed 12 Nov 2021.